CDH1 and neoplasm: In fact, several reports have shown that when epithelial tumor cells switch from expressing E-CAD to expressing N-CAD (cadherin switch phenomenon), they acquire the ability to activate Fibroblast Growth Factor Receptor (FGFR) pathways.